Edesa Biotech, Inc. (EDSA) Financials

EDSA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 7.8 million 2.0 million
2023-09-30 8.9 million 1.8 million
2023-06-30 9.4 million 1.6 million
2023-03-31 10.7 million 1.7 million

EDSA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -1.4 million 184357
2023-09-30 -1.5 million 517077
2023-06-30 -1.8 million 108159
2023-03-31 -1.6 million 287546

EDSA Net Income

No data available :(

EDSA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 4.3 million - 78314
2023-09-30 5.4 million - 94487
2023-06-30 6.5 million - 114921
2023-03-31 7.5 million - 129828

EDSA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 3.1 million
2023-09-30 2.9 million
2023-06-30 20.5 million
2023-03-31 20.0 million

EDSA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 704458 1.2 million 45031
2023-09-30 - 953399 1.4 million -
2023-06-30 - 1.0 million 1.0 million -
2023-03-31 - 1.5 million 952391 -

EDSA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 45031
2023-09-30 -1.1 million 45969
2023-06-30 - 82999
2023-03-31 - 27305

EDSA

Price: $4.55

52 week price:
2.46
8.33

Earnings Per Share: -20.16 USD

P/E Ratio: -0.24

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 79700

Market Capitalization: 14.9 million

Links: